Exploring Effectiveness and Safety of Nimotuzumab in Recurrent or Metastatic Cervical Cancer

被引：0
|
作者：
Liu, Z. [1 ]
Zhang, J. [1 ]
Zhang, Q. [1 ]
Wang, J. [1 ]
Wang, T. [1 ]
Shi, F. [1 ]
Su, J. [1 ]
Wang, F. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2577
引用
收藏
页码：E259 / E259
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB plus CHEMOTHERAPY FOR PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER IN JAPAN
    Akai, M.
    Moriwaki, K.
    Morimoto, K.
    Shimozuma, K.
    VALUE IN HEALTH, 2024, 27 (06) : S69 - S69
  • [32] Cost-effectiveness analysis of pembrolizumab plus chemotherapy for patients with recurrent or metastatic cervical cancer in China
    Zheng, Zhiwei
    Song, Xiaobing
    Qiu, Guodong
    Xu, Siqi
    Cai, Hongfu
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (03) : 433 - 440
  • [33] Bevacizumab in Metastatic, Recurrent, or Persistent Cervical Cancer The BC Cancer Experience
    Tinker, Anna V.
    Fiorino, Leathia
    O'Dwyer, Helena
    Kumar, Aalok
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1592 - 1599
  • [34] COST EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB AS FIRST-LINE TREATMENT FOR PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER IN GREECE
    Yfantopoulos, N.
    Gountas, I
    Swami, S.
    Skroumpelos, A.
    Karokis, A.
    VALUE IN HEALTH, 2023, 26 (12) : S62 - S62
  • [35] Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey
    Richardson, Michael T.
    Attwood, Kristopher
    Smith, Gabriella
    Liang, Su-Ying
    LaVigne Mager, Katherine
    Tewari, Krishnansu S.
    Coleman, Robert L.
    Kapp, Daniel S.
    Chan, John K.
    Monk, Bradley J.
    CANCER CONTROL, 2023, 30
  • [36] Efficacy of low dose nivolumab in recurrent / metastatic cervical cancer
    Devabhaktuni, S.
    Singh, A.
    Georgy, J. T.
    Antonisamy, J.
    Thumaty, D. B.
    John, A. O.
    ANNALS OF ONCOLOGY, 2023, 34 : S1585 - S1585
  • [37] Improving survival from metastatic, recurrent, or persistent cervical cancer
    Mileshkin, Linda R.
    Manoharan, Sathya
    LANCET, 2024, 403 (10421): : 2 - 4
  • [38] Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review
    Hirte, H. W.
    Strychowskyz, J. E.
    Oliverz, T.
    Fung-Kee-Fung, M.
    Elit, L.
    Oza, A. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (06) : 1194 - 1204
  • [39] Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
    Hong, David S.
    Concin, Nicole
    Vergote, Ignace
    de Bono, Johann S.
    Slomovitz, Brian M.
    Drew, Yvette
    Arkenau, Hendrik-Tobias
    Machiels, Jean-Pascal
    Spicer, James F.
    Jones, Robert
    Forster, Martin D.
    Cornez, Nathalie
    Gennigens, Christine
    Johnson, Melissa L.
    Thistlethwaite, Fiona C.
    Rangwala, Reshma A.
    Ghatta, Srinivas
    Windfeld, Kristian
    Harris, Jeffrey R.
    Lassen, Ulrik Niels
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1220 - 1228
  • [40] Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer
    Walker, Christopher
    McIntire, Donald
    Kakadiaris, Eugenia
    Makepeace, Lydia
    Edwards, Carson
    Lea, Jayanthi
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S94 - S95
12345